A Machine Learning Application to Classify Patients at Differing Levels of Risk of Opioid Use Disorder:
Tewodros Eguale1,2, François Bastardot3,4, Wenyu Song2,5
1School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, United States.
JMIR Medical Informatics
|June 6, 2024
Summary
Machine learning (ML) effectively identifies patients at risk for opioid use disorder (OUD), showing good agreement with clinician reviews. This technology promises to enhance opioid safety alerts and clinical decision-making.
Area of Science:
- Medical Informatics
- Clinical Decision Support
- Public Health
Background:
- Opioid use disorder (OUD) remains a significant public health challenge despite current management guidelines.
- Machine learning (ML) presents a potential solution for identifying and alerting clinicians to OUD.
- Early identification supports improved clinical decision-making for OUD treatment.
Purpose of the Study:
- To evaluate the clinical validity of an ML application for OUD risk detection.
- To compare ML-generated OUD risk alerts against structured clinician reviews of medical records.
Main Methods:
- An ML application analyzed outpatient data for 649,504 patients across two medical centers (2010-2013).
- A random sample of 180 patients was selected across three OUD risk categories.
- Clinicians performed systematic reviews to establish a consensus OUD risk level, compared against ML predictions.
Main Results:
- The ML application demonstrated good agreement with clinician assessments (weighted kappa = 0.62).
- For combined high-risk and OUD categories, ML achieved 56.6% sensitivity and 94.2% specificity.
- Key discrepancies between ML alerts and clinician reviews were identified and analyzed.
Conclusions:
- The ML application provides clinically valid alerts for varying OUD risk levels.
- ML tools show promise in identifying patients at risk for OUD.
- ML is expected to complement existing rule-based systems for opioid safety alerts.
Keywords:
AIEHROUDartificial intelligenceclinical decisionclinical decision supportdecision makingdecision supportdrug useelectronic health recordmachine learningmedicationmedication safetymodel validationopioid safetyopioid useopioid use disorderopioid-related disorderspatient medication safetypatient safetyMore Related Videos
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
234
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
234
Drug Abuse and Addiction: Pharmacological Phenomena
465
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
465
Opioid Analgesics: Synthetic and Semisynthetic Opioids
276
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
276
Opioid Receptors: Overview
729
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
729
Analgesia and Pain Management
579
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
579
Drug Classes and Categories
2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K


